Armistice Capital »

Mainz Biomed N V shares owned by Armistice Capital

Quarter-by-quarter ownership of Mainz Biomed N V (MYNZ) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Mainz Biomed N V

Tip: Access up to 7 years of quarterly data

All positions including Mainz Biomed N V held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mainz Biomed N V by Armistice Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $588k 395k 1.49
2024-12-31 $959k 222k 4.32

More positions owned by Armistice Capital

Iwm Nov5 230.0 P Listed Option Put Option (IWM)
Spy Nov5 634.0 P Listed Option Put Option (SPY)
Ptc Therapeutics Ord Equity (PTCT)
Travere Therapeutics Ord Equity (TVTX)
Supernus Pharmaceuticals Ord Equity (SUPN)
Cytk Jan7 40.0 C Listed Option Call Option (CYTK)
Madrigal Pharmaceuticals Ord Equity (MDGL)
Incyte Ord Equity (INCY)
Neurocrine Biosciences Ord Equity (NBIX)
Immunovant Ord Equity (IMVT)
Dentsply Sirona Ord Equity (XRAY)
Regeneron Pharmaceuticals Ord Equity (REGN)
Freshpet Ord Equity (FRPT)
Amazon Com Ord Equity (AMZN)
Agio Dec5 40.0 C Listed Option Call Option (AGIO)

View all positions for Armistice Capital

Top funds holding Mainz Biomed N V

Armistice Capital
Dauntless Investment Group
Journey Advisory Group
Steward Partners Investment Advisory
UBS Group
Advisor Group Holdings
Provenance Wealth Advisors
Morgan Stanley
Newbridge Financial Services Group
SBI Securities
IFP Advisors
Rothschild Investment

View all funds holding Mainz Biomed N V